StonvexLoading…
StonvexStonvexStonvexCore line items from JPM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $182.45B | $177.56B | $158.10B | $128.69B |
Operating Income | $72.59B | $75.08B | $61.61B | $46.17B |
Net Income | $57.05B | $58.47B | $49.55B | $37.68B |
EPS (Diluted) | $20.02 | $19.75 | $16.23 | $12.09 |
Total Assets | $4.42T | $4.00T | $3.88T | $3.67T |
Total Liabilities | $4.06T | $3.66T | $3.55T | $3.37T |
Cash & Equivalents | $343.34B | $469.32B | $624.15B | $567.23B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 2.70B | 2.80B | 2.88B | 2.93B |